Patents Assigned to Viscera Labs, Inc.
  • Therapeutic Composition and Methods
    Publication number: 20240050464
    Abstract: In exemplary embodiments, the disclosure provides a Colesevelam Colon Specific Drug Delivery System for use in treatment of, for example pruritus, a disorder related to elevated serum cholesterol concentration, or reducing elevated low-density lipoprotein cholesterol (LDL) concentration in a patient.
    Type: Application
    Filed: September 25, 2023
    Publication date: February 15, 2024
    Applicant: Viscera Labs, Inc.
    Inventors: Stephen TAGLIENTI, Steven L. PETRUCCELLI
  • Therapeutic composition and methods
    Patent number: 11813283
    Abstract: In exemplary embodiments, the disclosure provides a Colesevelam Colon Specific Drug Delivery System for use in treatment of, for example insufficient glycemic control in a patient.
    Type: Grant
    Filed: November 28, 2022
    Date of Patent: November 14, 2023
    Assignee: Viscera Labs, Inc.
    Inventors: Stephen Taglienti, Steven L. Petruccelli
  • Therapeutic composition and methods
    Patent number: 11590161
    Abstract: In exemplary embodiments, the disclosure provides a Colesevelam Colon Specific Drug Delivery System for use in treatment of, for example, cholestasis and/or cholestatic pruritus.
    Type: Grant
    Filed: February 12, 2020
    Date of Patent: February 28, 2023
    Assignee: Viscera Labs, Inc.
    Inventors: Stephen Taglienti, Steven L. Petruccelli
  • Therapeutic composition and methods
    Patent number: 11524029
    Abstract: In exemplary embodiments, the disclosure provides a Colesevelam Colon Specific Drug Delivery System for use in treatment of, for example, cholestasis and/or cholestatic pruritus.
    Type: Grant
    Filed: August 12, 2019
    Date of Patent: December 13, 2022
    Assignee: Viscera Labs, Inc.
    Inventors: Stephen Taglienti, Steven L. Petruccelli